Free Trial
→ Musk’s Project Colossus could mint millionaires (From Brownstone Research) (Ad)tc pixel Free CANF Stock Alerts

Can-Fite BioPharma (CANF) SEC Filings & 10K Form

Can-Fite BioPharma logo
$0.63 -0.03 (-4.84%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$0.64 +0.01 (+2.15%)
As of 08/29/2025 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Can-Fite BioPharma SEC Filings

Export to Excel
DateFilerForm TypeView
08/28/2025
3:15 PM		Can-Fite BioPharma (Filer)
Form POS AM
08/28/2025
3:17 PM		Can-Fite BioPharma (Filer)
Form POS AM
08/28/2025
7:49 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2025
6:08 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2025
8:57 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2025
9:03 AM		Can-Fite BioPharma (Filer)
Form 424B4
07/28/2025
11:15 PM		Can-Fite BioPharma (Filer)
Form EFFECT
07/28/2025
6:02 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2025
1:34 PM		Can-Fite BioPharma (Filer)
Form F-1/A
06/23/2025
3:15 PM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2025
8:02 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2025
7:10 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2025
3:30 PM		Can-Fite BioPharma (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G/A
04/17/2025
11:15 PM		Can-Fite BioPharma (Filer)
Form EFFECT
04/17/2025
8:16 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
3:30 PM		Can-Fite BioPharma (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G
04/15/2025
11:35 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
11:37 AM		Can-Fite BioPharma (Filer)
Form 424B5
04/14/2025
3:15 PM		Can-Fite BioPharma (Filer)
Form POS AM
04/14/2025
7:35 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2025
7:00 AM		Can-Fite BioPharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/14/2025
7:05 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/24/2025
8:01 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2025
8:45 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
8:02 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2025
7:32 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
5:04 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
6:04 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
4:33 PM		ARMISTICE CAPITAL, LLC (Filed by)
Can-Fite BioPharma (Subject)
Form SCHEDULE 13G/A
02/05/2025
6:02 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
6:03 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
6:01 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
6:05 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:09 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2024
8:23 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
6:03 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
6:05 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
6:07 AM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2024
11:15 PM		Can-Fite BioPharma (Filer)
Form EFFECT
09/06/2024
3:30 PM		Can-Fite BioPharma (Filer)
Form 424B3
09/05/2024
11:15 PM		Can-Fite BioPharma (Filer)
Form EFFECT
When the levee breaks (Ad)

The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.tc pixel

Click here to watch the urgent broadcast and get ahead of what’s coming.
08/30/2024
3:18 PM		Can-Fite BioPharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
08/30/2024
3:18 PM		Can-Fite BioPharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:CANF) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...
Altimetry | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsoredtc pixel
My NEXT $1 Trillion Prediction
James Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...
Paradigm Press | Sponsoredtc pixel
Trump’s national nightmare is here
AI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...
Porter & Company | Sponsoredtc pixel